-
Ab182893-5mgBepranemab (anti-Tau) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab (anti-Tau) can be used for Alzheimer’s disease (AD) research.Purity>:95% (SDS-PAGE&:SEC)Endotoxin
-
Ab182893-1mgBepranemab (anti-Tau) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab (anti-Tau) can be used for Alzheimer’s disease (AD) research.Purity>:95% (SDS-PAGE&:SEC)Endotoxin
-
Ab182893-10mgBepranemab (anti-Tau) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab (anti-Tau) can be used for Alzheimer’s disease (AD) research.Purity>:95% (SDS-PAGE&:SEC)Endotoxin
-
Ab182893-100μgBepranemab (anti-Tau) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab (anti-Tau) can be used for Alzheimer’s disease (AD) research.Purity>:95% (SDS-PAGE&:SEC)Endotoxin
-
Ab182891-5mgRipertamab (anti-CD20) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab (anti-CD20) can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL).Purity>:95% (SDS-PAGE&:SEC)Endotoxin
-
Ab182891-1mgRipertamab (anti-CD20) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab (anti-CD20) can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL).Purity>:95% (SDS-PAGE&:SEC)Endotoxin
-
Ab182891-10mgRipertamab (anti-CD20) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab (anti-CD20) can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL).Purity>:95% (SDS-PAGE&:SEC)Endotoxin
-
Ab182891-100μgRipertamab (anti-CD20) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab (anti-CD20) can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL).Purity>:95% (SDS-PAGE&:SEC)Endotoxin
-
Ab182878-5mgManelimab (anti-PD-L1) is a monoclonal antibody that inhibits programmed death-ligand 1 (PD-L1).Purity>:95% (SDS-PAGE&:SEC)Endotoxin Level <: 0.01EU/μg.
-
Ab182878-1mgManelimab (anti-PD-L1) is a monoclonal antibody that inhibits programmed death-ligand 1 (PD-L1).Purity>:95% (SDS-PAGE&:SEC)Endotoxin Level <: 0.01EU/μg.
-
Ab182878-10mgManelimab (anti-PD-L1) is a monoclonal antibody that inhibits programmed death-ligand 1 (PD-L1).Purity>:95% (SDS-PAGE&:SEC)Endotoxin Level <: 0.01EU/μg.
-
Ab182878-100μgManelimab (anti-PD-L1) is a monoclonal antibody that inhibits programmed death-ligand 1 (PD-L1).Purity>:95% (SDS-PAGE&:SEC)Endotoxin Level <: 0.01EU/μg.